Thomas Asbury

Title: The Innovations of Thomas Asbury

Introduction

Thomas Asbury is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of genotyping and cancer analysis. With a total of four patents to his name, Asbury's work has the potential to impact medical diagnostics and treatment.

Latest Patents

One of Asbury's latest patents is a method for genotyping clonotype profiles using sequence tags. This invention focuses on sequence-based profiling of populations of nucleic acids through multiplex amplification and the attachment of sequence tags to target nucleic acids. The process is followed by high-throughput sequencing of the amplification product. The invention includes successive steps of primer extension, removal of unextended primers, and the addition of new primers for amplification or further primer extensions. Notably, some embodiments of this invention are directed towards minimal residual disease (MRD) analysis in cancer patients. The incorporation of sequence tags into sequence reads allows for efficient determination of clonotypes and helps detect carry-over contamination from other samples tested in the same laboratory.

Career Highlights

Asbury is currently associated with Adaptive Biotechnologies Corporation, where he continues to innovate in the field of biotechnology. His work is crucial in advancing the understanding and treatment of various diseases, particularly cancer.

Collaborations

Asbury collaborates with talented individuals such as Malek Faham and Martin Moorhead, contributing to a dynamic research environment that fosters innovation.

Conclusion

Thomas Asbury's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also has the potential to improve patient outcomes in cancer treatment.